Together, these findings indicate an intricate relationship between Skp2 and β-TrCP in energy-restricted cancer cells in which downregulated Skp2 expression is involved in the glycolysis inhibitor-induced accumulation of β-TrCP, which in turn contributes to the reduced expression of Skp2. The gene discussed is BTRC; the disease is cancer.